世界のグリア細胞株由来神経栄養因子市場規模・現状・予測（2021年-2027年）

• 英文タイトル：Global Glial Cell Line Derived Neurotrophic Factor Market Size, Status and Forecast 2021-2027

• レポートコード：QFJ1-5755 • 出版社/出版日：QYResearch / 2021年6月 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、87ページ • 納品方法：Eメール（納期：3日） • 産業分類：医薬品

• 販売価格（消費税別）

Single User	￥577,200 (USD3,900)	▷ お問い合わせ
Multi User	￥865,800 (USD5,850)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

QYResearch社発行の本調査レポートでは、グリア細胞株由来神経栄養因子の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（GSK-812、LAUR-301、TW-002、AMT-090、その他）、用途別市場規模（筋萎縮性側索硬化症、脳虚血、パーキンソン病、網膜変性、その他）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、企業情報などをまとめております。 ・市場概要 ・グリア細胞株由来神経栄養因子の市場動向 ・企業の競争状況、市場シェア ・グリア細胞株由来神経栄養因子の種類別市場規模と予測2016-2027（GSK-812、LAUR-301、TW-002、AMT-090、その他） ・グリア細胞株由来神経栄養因子の用途別市場規模と予測2016-2027（筋萎縮性側索硬化症、脳虚血、パーキンソン病、網膜変性、その他） ・グリア細胞株由来神経栄養因子の北米市場規模2016-2027（アメリカ、カナダ） ・グリア細胞株由来神経栄養因子の欧州市場規模2016-2027（ドイツ、フランス、イギリス等） ・グリア細胞株由来神経栄養因子のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・グリア細胞株由来神経栄養因子の中南米市場規模2016-2027（メキシコ、ブラジル） ・グリア細胞株由来神経栄養因子の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（GlaxoSmithKline Plc、Treeway BV、UniQure NV） ・結論

Market Analysis and Insights: Global Glial Cell Line Derived Neurotrophic Factor Market
The global Glial Cell Line Derived Neurotrophic Factor market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Glial Cell Line Derived Neurotrophic Factor market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Glial Cell Line Derived Neurotrophic Factor market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Glial Cell Line Derived Neurotrophic Factor market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Glial Cell Line Derived Neurotrophic Factor market.

Global Glial Cell Line Derived Neurotrophic Factor Scope and Market Size
Glial Cell Line Derived Neurotrophic Factor market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Glial Cell Line Derived Neurotrophic Factor market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
GSK-812
LAUR-301
TW-002
AMT-090
Others

Segment by Application
Amyotrophic Lateral Sclerosis
Brain Ischemia
Parkinson’s Disease
Retinal Degeneration
Others

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
GlaxoSmithKline Plc
Treeway BV
UniQure NV

レポート目次

---

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Glial Cell Line Derived Neurotrophic Factor Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 GSK-812
1.2.3 LAUR-301
1.2.4 TW-002
1.2.5 AMT-090
1.2.6 Others
1.3 Market by Application
1.3.1 Global Glial Cell Line Derived Neurotrophic Factor Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Amyotrophic Lateral Sclerosis
1.3.3 Brain Ischemia
1.3.4 Parkinson’s Disease
1.3.5 Retinal Degeneration
1.3.6 Others
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Glial Cell Line Derived Neurotrophic Factor Market Perspective (2016-2027)
2.2 Glial Cell Line Derived Neurotrophic Factor Growth Trends by Regions
2.2.1 Glial Cell Line Derived Neurotrophic Factor Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Glial Cell Line Derived Neurotrophic Factor Historic Market Share by Regions (2016-2021)
2.2.3 Glial Cell Line Derived Neurotrophic Factor Forecasted Market Size by Regions (2022-2027)
2.3 Glial Cell Line Derived Neurotrophic Factor Industry Dynamic
2.3.1 Glial Cell Line Derived Neurotrophic Factor Market Trends
2.3.2 Glial Cell Line Derived Neurotrophic Factor Market Drivers
2.3.3 Glial Cell Line Derived Neurotrophic Factor Market Challenges
2.3.4 Glial Cell Line Derived Neurotrophic Factor Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Glial Cell Line Derived Neurotrophic Factor Players by Revenue
3.1.1 Global Top Glial Cell Line Derived Neurotrophic Factor Players by Revenue (2016-2021)
3.1.2 Global Glial Cell Line Derived Neurotrophic Factor Revenue Market Share by Players (2016-2021)
3.2 Global Glial Cell Line Derived Neurotrophic Factor Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Glial Cell Line Derived Neurotrophic Factor Revenue
3.4 Global Glial Cell Line Derived Neurotrophic Factor Market Concentration Ratio
3.4.1 Global Glial Cell Line Derived Neurotrophic Factor Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Glial Cell Line Derived Neurotrophic Factor Revenue in 2020
3.5 Glial Cell Line Derived Neurotrophic Factor Key Players Head office and Area Served
3.6 Key Players Glial Cell Line Derived Neurotrophic Factor Product Solution and Service
3.7 Date of Enter into Glial Cell Line Derived Neurotrophic Factor Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Glial Cell Line Derived Neurotrophic Factor Breakdown Data by Type
4.1 Global Glial Cell Line Derived Neurotrophic Factor Historic Market Size by Type (2016-2021)
4.2 Global Glial Cell Line Derived Neurotrophic Factor Forecasted Market Size by Type (2022-2027)

5 Glial Cell Line Derived Neurotrophic Factor Breakdown Data by Application
5.1 Global Glial Cell Line Derived Neurotrophic Factor Historic Market Size by Application (2016-2021)
5.2 Global Glial Cell Line Derived Neurotrophic Factor Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Glial Cell Line Derived Neurotrophic Factor Market Size (2016-2027)
6.2 North America Glial Cell Line Derived Neurotrophic Factor Market Size by Type
6.2.1 North America Glial Cell Line Derived Neurotrophic Factor Market Size by Type (2016-2021)
6.2.2 North America Glial Cell Line Derived Neurotrophic Factor Market Size by Type (2022-2027)
6.2.3 North America Glial Cell Line Derived Neurotrophic Factor Market Size by Type (2016-2027)
6.3 North America Glial Cell Line Derived Neurotrophic Factor Market Size by Application
6.3.1 North America Glial Cell Line Derived Neurotrophic Factor Market Size by Application (2016-2021)
6.3.2 North America Glial Cell Line Derived Neurotrophic Factor Market Size by Application (2022-2027)
6.3.3 North America Glial Cell Line Derived Neurotrophic Factor Market Size by Application (2016-2027)
6.4 North America Glial Cell Line Derived Neurotrophic Factor Market Size by Country
6.4.1 North America Glial Cell Line Derived Neurotrophic Factor Market Size by Country (2016-2021)
6.4.2 North America Glial Cell Line Derived Neurotrophic Factor Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada

7 Europe
7.1 Europe Glial Cell Line Derived Neurotrophic Factor Market Size (2016-2027)
7.2 Europe Glial Cell Line Derived Neurotrophic Factor Market Size by Type
7.2.1 Europe Glial Cell Line Derived Neurotrophic Factor Market Size by Type (2016-2021)
7.2.2 Europe Glial Cell Line Derived Neurotrophic Factor Market Size by Type (2022-2027)
7.2.3 Europe Glial Cell Line Derived Neurotrophic Factor Market Size by Type (2016-2027)
7.3 Europe Glial Cell Line Derived Neurotrophic Factor Market Size by Application
7.3.1 Europe Glial Cell Line Derived Neurotrophic Factor Market Size by Application (2016-2021)
7.3.2 Europe Glial Cell Line Derived Neurotrophic Factor Market Size by Application (2022-2027)
7.3.3 Europe Glial Cell Line Derived Neurotrophic Factor Market Size by Application (2016-2027)
7.4 Europe Glial Cell Line Derived Neurotrophic Factor Market Size by Country
7.4.1 Europe Glial Cell Line Derived Neurotrophic Factor Market Size by Country (2016-2021)
7.4.2 Europe Glial Cell Line Derived Neurotrophic Factor Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Glial Cell Line Derived Neurotrophic Factor Market Size (2016-2027)
8.2 Asia-Pacific Glial Cell Line Derived Neurotrophic Factor Market Size by Type
8.2.1 Asia-Pacific Glial Cell Line Derived Neurotrophic Factor Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Glial Cell Line Derived Neurotrophic Factor Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Glial Cell Line Derived Neurotrophic Factor Market Size by Type (2016-2027)
8.3 Asia-Pacific Glial Cell Line Derived Neurotrophic Factor Market Size by Application
8.3.1 Asia-Pacific Glial Cell Line Derived Neurotrophic Factor Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Glial Cell Line Derived Neurotrophic Factor Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Glial Cell Line Derived Neurotrophic Factor Market Size by Application (2016-2027)
8.4 Asia-Pacific Glial Cell Line Derived Neurotrophic Factor Market Size by Region
8.4.1 Asia-Pacific Glial Cell Line Derived Neurotrophic Factor Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Glial Cell Line Derived Neurotrophic Factor Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Glial Cell Line Derived Neurotrophic Factor Market Size (2016-2027)
9.2 Latin America Glial Cell Line Derived Neurotrophic Factor Market Size by Type
9.2.1 Latin America Glial Cell Line Derived Neurotrophic Factor Market Size by Type (2016-2021)
9.2.2 Latin America Glial Cell Line Derived Neurotrophic Factor Market Size by Type (2022-2027)
9.2.3 Latin America Glial Cell Line Derived Neurotrophic Factor Market Size by Type (2016-2027)
9.3 Latin America Glial Cell Line Derived Neurotrophic Factor Market Size by Application
9.3.1 Latin America Glial Cell Line Derived Neurotrophic Factor Market Size by Application (2016-2021)
9.3.2 Latin America Glial Cell Line Derived Neurotrophic Factor Market Size by Application (2022-2027)
9.3.3 Latin America Glial Cell Line Derived Neurotrophic Factor Market Size by Application (2016-2027)
9.4 Latin America Glial Cell Line Derived Neurotrophic Factor Market Size by Country
9.4.1 Latin America Glial Cell Line Derived Neurotrophic Factor Market Size by Country (2016-2021)
9.4.2 Latin America Glial Cell Line Derived Neurotrophic Factor Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Glial Cell Line Derived Neurotrophic Factor Market Size (2016-2027)
10.2 Middle East & Africa Glial Cell Line Derived Neurotrophic Factor Market Size by Type
10.2.1 Middle East & Africa Glial Cell Line Derived Neurotrophic Factor Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Glial Cell Line Derived Neurotrophic Factor Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Glial Cell Line Derived Neurotrophic Factor Market Size by Type (2016-2027)
10.3 Middle East & Africa Glial Cell Line Derived Neurotrophic Factor Market Size by Application
10.3.1 Middle East & Africa Glial Cell Line Derived Neurotrophic Factor Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Glial Cell Line Derived Neurotrophic Factor Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Glial Cell Line Derived Neurotrophic Factor Market Size by Application (2016-2027)
10.4 Middle East & Africa Glial Cell Line Derived Neurotrophic Factor Market Size by Country
10.4.1 Middle East & Africa Glial Cell Line Derived Neurotrophic Factor Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Glial Cell Line Derived Neurotrophic Factor Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 GlaxoSmithKline Plc
11.1.1 GlaxoSmithKline Plc Company Details
11.1.2 GlaxoSmithKline Plc Business Overview
11.1.3 GlaxoSmithKline Plc Glial Cell Line Derived Neurotrophic Factor Introduction
11.1.4 GlaxoSmithKline Plc Revenue in Glial Cell Line Derived Neurotrophic Factor Business (2016-2021)
11.1.5 GlaxoSmithKline Plc Recent Development
11.2 Treeway BV
11.2.1 Treeway BV Company Details
11.2.2 Treeway BV Business Overview
11.2.3 Treeway BV Glial Cell Line Derived Neurotrophic Factor Introduction
11.2.4 Treeway BV Revenue in Glial Cell Line Derived Neurotrophic Factor Business (2016-2021)
11.2.5 Treeway BV Recent Development
11.3 UniQure NV
11.3.1 UniQure NV Company Details
11.3.2 UniQure NV Business Overview
11.3.3 UniQure NV Glial Cell Line Derived Neurotrophic Factor Introduction
11.3.4 UniQure NV Revenue in Glial Cell Line Derived Neurotrophic Factor Business (2016-2021)
11.3.5 UniQure NV Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global Glial Cell Line Derived Neurotrophic Factor Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of GSK-812
Table 3. Key Players of LAUR-301
Table 4. Key Players of TW-002
Table 5. Key Players of AMT-090
Table 6. Key Players of Others
Table 7. Global Glial Cell Line Derived Neurotrophic Factor Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 8. Global Glial Cell Line Derived Neurotrophic Factor Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 9. Global Glial Cell Line Derived Neurotrophic Factor Market Size by Regions (2016-2021) & (US$ Million)
Table 10. Global Glial Cell Line Derived Neurotrophic Factor Market Share by Regions (2016-2021)
Table 11. Global Glial Cell Line Derived Neurotrophic Factor Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 12. Global Glial Cell Line Derived Neurotrophic Factor Market Share by Regions (2022-2027)
Table 13. Glial Cell Line Derived Neurotrophic Factor Market Trends
Table 14. Glial Cell Line Derived Neurotrophic Factor Market Drivers
Table 15. Glial Cell Line Derived Neurotrophic Factor Market Challenges
Table 16. Glial Cell Line Derived Neurotrophic Factor Market Restraints
Table 17. Global Glial Cell Line Derived Neurotrophic Factor Revenue by Players (2016-2021) & (US$ Million)
Table 18. Global Glial Cell Line Derived Neurotrophic Factor Market Share by Players (2016-2021)
Table 19. Global Top Glial Cell Line Derived Neurotrophic Factor Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Glial Cell Line Derived Neurotrophic Factor as of 2020)
Table 20. Ranking of Global Top Glial Cell Line Derived Neurotrophic Factor Companies by Revenue (US$ Million) in 2020
Table 21. Global 5 Largest Players Market Share by Glial Cell Line Derived Neurotrophic Factor Revenue (CR5 and HHI) & (2016-2021)
Table 22. Key Players Headquarters and Area Served
Table 23. Key Players Glial Cell Line Derived Neurotrophic Factor Product Solution and Service
Table 24. Date of Enter into Glial Cell Line Derived Neurotrophic Factor Market
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global Glial Cell Line Derived Neurotrophic Factor Market Size by Type (2016-2021) (US$ Million)
Table 27. Global Glial Cell Line Derived Neurotrophic Factor Revenue Market Share by Type (2016-2021)
Table 28. Global Glial Cell Line Derived Neurotrophic Factor Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 29. Global Glial Cell Line Derived Neurotrophic Factor Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 30. Global Glial Cell Line Derived Neurotrophic Factor Market Size Share by Application (2016-2021) & (US$ Million)
Table 31. Global Glial Cell Line Derived Neurotrophic Factor Revenue Market Share by Application (2016-2021)
Table 32. Global Glial Cell Line Derived Neurotrophic Factor Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 33. Global Glial Cell Line Derived Neurotrophic Factor Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 34. North America Glial Cell Line Derived Neurotrophic Factor Market Size by Type (2016-2021) (US$ Million)
Table 35. North America Glial Cell Line Derived Neurotrophic Factor Market Size by Type (2022-2027) & (US$ Million)
Table 36. North America Glial Cell Line Derived Neurotrophic Factor Market Size by Application (2016-2021) (US$ Million)
Table 37. North America Glial Cell Line Derived Neurotrophic Factor Market Size by Application (2022-2027) & (US$ Million)
Table 38. North America Glial Cell Line Derived Neurotrophic Factor Market Size by Country (2016-2021) & (US$ Million)
Table 39. North America Glial Cell Line Derived Neurotrophic Factor Market Size by Country (2022-2027) & (US$ Million)
Table 40. Europe Glial Cell Line Derived Neurotrophic Factor Market Size by Type (2016-2021) (US$ Million)
Table 41. Europe Glial Cell Line Derived Neurotrophic Factor Market Size by Type (2022-2027) & (US$ Million)
Table 42. Europe Glial Cell Line Derived Neurotrophic Factor Market Size by Application (2016-2021) (US$ Million)
Table 43. Europe Glial Cell Line Derived Neurotrophic Factor Market Size by Application (2022-2027) & (US$ Million)
Table 44. Europe Glial Cell Line Derived Neurotrophic Factor Market Size by Country (2016-2021) & (US$ Million)
Table 45. Europe Glial Cell Line Derived Neurotrophic Factor Market Size by Country (2022-2027) & (US$ Million)
Table 46. Asia-Pacific Glial Cell Line Derived Neurotrophic Factor Market Size by Type (2016-2021) (US$ Million)
Table 47. Asia-Pacific Glial Cell Line Derived Neurotrophic Factor Market Size by Type (2022-2027) & (US$ Million)
Table 48. Asia-Pacific Glial Cell Line Derived Neurotrophic Factor Market Size by Application (2016-2021) (US$ Million)
Table 49. Asia-Pacific Glial Cell Line Derived Neurotrophic Factor Market Size by Application (2022-2027) & (US$ Million)
Table 50. Asia-Pacific Glial Cell Line Derived Neurotrophic Factor Market Size by Region (2016-2021) & (US$ Million)
Table 51. Asia-Pacific Glial Cell Line Derived Neurotrophic Factor Market Size by Region (2022-2027) & (US$ Million)
Table 52. Latin America Glial Cell Line Derived Neurotrophic Factor Market Size by Type (2016-2021) (US$ Million)
Table 53. Latin America Glial Cell Line Derived Neurotrophic Factor Market Size by Type (2022-2027) & (US$ Million)
Table 54. Latin America Glial Cell Line Derived Neurotrophic Factor Market Size by Application (2016-2021) (US$ Million)
Table 55. Latin America Glial Cell Line Derived Neurotrophic Factor Market Size by Application (2022-2027) & (US$ Million)
Table 56. Latin America Glial Cell Line Derived Neurotrophic Factor Market Size by Country (2016-2021) & (US$ Million)
Table 57. Latin America Glial Cell Line Derived Neurotrophic Factor Market Size by Country (2022-2027) & (US$ Million)
Table 58. Middle East & Africa Glial Cell Line Derived Neurotrophic Factor Market Size by Type (2016-2021) (US$ Million)
Table 59. Middle East & Africa Glial Cell Line Derived Neurotrophic Factor Market Size by Type (2022-2027) & (US$ Million)
Table 60. Middle East & Africa Glial Cell Line Derived Neurotrophic Factor Market Size by Application (2016-2021) (US$ Million)
Table 61. Middle East & Africa Glial Cell Line Derived Neurotrophic Factor Market Size by Application (2022-2027) & (US$ Million)
Table 62. Middle East & Africa Glial Cell Line Derived Neurotrophic Factor Market Size by Country (2016-2021) & (US$ Million)
Table 63. Middle East & Africa Glial Cell Line Derived Neurotrophic Factor Market Size by Country (2022-2027) & (US$ Million)
Table 64. GlaxoSmithKline Plc Company Details
Table 65. GlaxoSmithKline Plc Business Overview
Table 66. GlaxoSmithKline Plc Glial Cell Line Derived Neurotrophic Factor Product
Table 67. GlaxoSmithKline Plc Revenue in Glial Cell Line Derived Neurotrophic Factor Business (2016-2021) & (US$ Million)
Table 68. GlaxoSmithKline Plc Recent Development
Table 69. Treeway BV Company Details
Table 70. Treeway BV Business Overview
Table 71. Treeway BV Glial Cell Line Derived Neurotrophic Factor Product
Table 72. Treeway BV Revenue in Glial Cell Line Derived Neurotrophic Factor Business (2016-2021) & (US$ Million)
Table 73. Treeway BV Recent Development
Table 74. UniQure NV Company Details
Table 75. UniQure NV Business Overview
Table 76. UniQure NV Glial Cell Line Derived Neurotrophic Factor Product
Table 77. UniQure NV Revenue in Glial Cell Line Derived Neurotrophic Factor Business (2016-2021) & (US$ Million)
Table 78. UniQure NV Recent Development
Table 79. Research Programs/Design for This Report
Table 80. Key Data Information from Secondary Sources
Table 81. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Glial Cell Line Derived Neurotrophic Factor Market Share by Type: 2020 VS 2027
Figure 2. GSK-812 Features
Figure 3. LAUR-301 Features
Figure 4. TW-002 Features
Figure 5. AMT-090 Features
Figure 6. Others Features
Figure 7. Global Glial Cell Line Derived Neurotrophic Factor Market Share by Application: 2020 VS 2027
Figure 8. Amyotrophic Lateral Sclerosis Case Studies
Figure 9. Brain Ischemia Case Studies
Figure 10. Parkinson's Disease Case Studies
Figure 11. Retinal Degeneration Case Studies
Figure 12. Others Case Studies
Figure 13. Glial Cell Line Derived Neurotrophic Factor Report Years Considered
Figure 14. Global Glial Cell Line Derived Neurotrophic Factor Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 15. Global Glial Cell Line Derived Neurotrophic Factor Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 16. Global Glial Cell Line Derived Neurotrophic Factor Market Share by Regions: 2020 VS 2027
Figure 17. Global Glial Cell Line Derived Neurotrophic Factor Market Share by Regions (2022-2027)
Figure 18. Global Glial Cell Line Derived Neurotrophic Factor Market Share by Players in 2020
Figure 19. Global Top Glial Cell Line Derived Neurotrophic Factor Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Glial Cell Line Derived Neurotrophic Factor as of 2020
Figure 20. The Top 10 and 5 Players Market Share by Glial Cell Line Derived Neurotrophic Factor Revenue in 2020
Figure 21. Global Glial Cell Line Derived Neurotrophic Factor Revenue Market Share by Type (2016-2021)
Figure 22. Global Glial Cell Line Derived Neurotrophic Factor Revenue Market Share by Type (2022-2027)
Figure 23. North America Glial Cell Line Derived Neurotrophic Factor Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 24. North America Glial Cell Line Derived Neurotrophic Factor Market Share by Type (2016-2027)
Figure 25. North America Glial Cell Line Derived Neurotrophic Factor Market Share by Application (2016-2027)
Figure 26. North America Glial Cell Line Derived Neurotrophic Factor Market Share by Country (2016-2027)
Figure 27. United States Glial Cell Line Derived Neurotrophic Factor Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 28. Canada Glial Cell Line Derived Neurotrophic Factor Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 29. Europe Glial Cell Line Derived Neurotrophic Factor Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 30. Europe Glial Cell Line Derived Neurotrophic Factor Market Share by Type (2016-2027)
Figure 31. Europe Glial Cell Line Derived Neurotrophic Factor Market Share by Application (2016-2027)
Figure 32. Europe Glial Cell Line Derived Neurotrophic Factor Market Share by Country (2016-2027)
Figure 33. Germany Glial Cell Line Derived Neurotrophic Factor Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. France Glial Cell Line Derived Neurotrophic Factor Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. U.K. Glial Cell Line Derived Neurotrophic Factor Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Italy Glial Cell Line Derived Neurotrophic Factor Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. Russia Glial Cell Line Derived Neurotrophic Factor Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 38. Nordic Glial Cell Line Derived Neurotrophic Factor Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 39. Asia-Pacific Glial Cell Line Derived Neurotrophic Factor Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 40. Asia-Pacific Glial Cell Line Derived Neurotrophic Factor Market Share by Type (2016-2027)
Figure 41. Asia-Pacific Glial Cell Line Derived Neurotrophic Factor Market Share by Application (2016-2027)
Figure 42. Asia-Pacific Glial Cell Line Derived Neurotrophic Factor Market Share by Region (2016-2027)
Figure 43. China Glial Cell Line Derived Neurotrophic Factor Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Japan Glial Cell Line Derived Neurotrophic Factor Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. South Korea Glial Cell Line Derived Neurotrophic Factor Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Southeast Asia Glial Cell Line Derived Neurotrophic Factor Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. India Glial Cell Line Derived Neurotrophic Factor Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 48. Australia Glial Cell Line Derived Neurotrophic Factor Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 49. Latin America Glial Cell Line Derived Neurotrophic Factor Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 50. Latin America Glial Cell Line Derived Neurotrophic Factor Market Share by Type (2016-2027)
Figure 51. Latin America Glial Cell Line Derived Neurotrophic Factor Market Share by Application (2016-2027)
Figure 52. Latin America Glial Cell Line Derived Neurotrophic Factor Market Share by Country (2016-2027)
Figure 53. Mexico Glial Cell Line Derived Neurotrophic Factor Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 54. Brazil Glial Cell Line Derived Neurotrophic Factor Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 55. Middle East & Africa Glial Cell Line Derived Neurotrophic Factor Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 56. Middle East & Africa Glial Cell Line Derived Neurotrophic Factor Market Share by Type (2016-2027)
Figure 57. Middle East & Africa Glial Cell Line Derived Neurotrophic Factor Market Share by Application (2016-2027)
Figure 58. Middle East & Africa Glial Cell Line Derived Neurotrophic Factor Market Share by Country (2016-2027)
Figure 59. Turkey Glial Cell Line Derived Neurotrophic Factor Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 60. Saudi Arabia Glial Cell Line Derived Neurotrophic Factor Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 61. UAE Glial Cell Line Derived Neurotrophic Factor Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 62. GlaxoSmithKline Plc Revenue Growth Rate in Glial Cell Line Derived Neurotrophic Factor Business (2016-2021)
Figure 63. Treeway BV Revenue Growth Rate in Glial Cell Line Derived Neurotrophic Factor Business (2016-2021)
Figure 64. UniQure NV Revenue Growth Rate in Glial Cell Line Derived Neurotrophic Factor Business (2016-2021)
Figure 65. Bottom-up and Top-down Approaches for This Report
Figure 66. Data Triangulation
Figure 67. Key Executives Interviewed

---